Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Disturbances in sexual function are common in patients with chronic kidney disease. Such disturbances include erectile dysfunction, decreased libido, and marked declines in the frequency of intercourse. Sexual dysfunction is multifactorial and primarily organic in origin. In addition to the uremic milieu, peripheral neuropathy, autonomic insufficiency, peripheral vascular disease and pharmacologic therapy all play an important role in the genesis of these problems. In addition, psychological and physical stresses are also commonly present in this setting.
Erectile dysfunction is one of the most common manifestations of sexual dysfunction in men with chronic kidney disease. The prevalence of this disorder has been reported to be as high as 70%–80% and is similar between patients on hemodialysis and peritoneal dialysis. A recent multinational cross-sectional study of 946 men on hemodialysis within a collaborative network examined the frequency of erectile dysfunction and depressive symptoms. Eighty-three percent reported erectile dysfunction and 47% reported severe erectile dysfunction. Only 4% of those with erectile dysfunction were receiving pharmacological treatment suggesting most men on hemodialysis experience erectile dysfunction and are untreated. The high prevalence of this disorder is not surprising given that many of the diseases such as atherosclerosis, diabetes, and hypertension that are associated with erectile dysfunction are commonly found in patients with chronic kidney disease. Normal male sexual function is achieved through the integrative response of the vascular, neurologic, endocrine, and psychologic systems. Men with chronic kidney disease can exhibit abnormalities in any one or all of these systems ( Table 16.1 ). Before discussing changes in sex hormones accompanying the loss of renal function, a brief discussion of other comorbidities contributing to this disorder will be presented.
Vascular system |
Occlusive arterial disease |
Venoocclusive disease and venous leakage |
Neurologic system |
Impaired autonomic function due to uremia and comorbid conditions |
Endocrine system |
Psychologic system |
Other factors |
Zinc deficiency |
Medications |
Anemia |
Secondary hyperparathyroidism |
Normal erections require blood to flow from the hypogastric arterial system into specialized erectile chambers, including the paired corpora cavernosae flanking the penile urethra and the corpus spongiosum at the glans penis. As blood flow accelerates, the pressure within the intracavernosal spaces increases dramatically to choke off penile venous outflow from emissary veins. This combination of increased intracavernosal blood flow and reduced venous outflow allows a man to acquire and maintain a firm erection.
Studies in patients with chronic kidney disease have shown that vascular causes of erectile dysfunction are common. Decreased arterial inflow has been demonstrated to result from occlusive disease of the cavernosal artery. Erectile dysfunction can also result from occlusive disease in the more proximal ileac and pudendal arteries by producing a pelvic arterial steal syndrome. This syndrome results from blood being diverted from the corpus cavernosa to meet the oxygen requirements of the pelvis. In addition to reductions in arterial inflow many patients have evidence of venoocclusive dysfunction. Such abnormalities lead to venous leakage and therefore inability to achieve or maintain an erection.
Erectile dysfunction in nonuremic men has been identified as a marker of atherosclerosis and endothelial dysfunction in other vascular beds to include the coronary circulation. Erectile dysfunction is more common in men with evidence of coronary endothelial dysfunction as compared to those with normal function. Such patients have increased circulating levels of the nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), suggesting a reduction of endogenous nitric oxide activity may be responsible for the abnormal vascular behavior. It is likely that a similar relationship exists between erectile dysfunction and vascular disease in uremic men given the high frequency of both disorders.
Significant portions of chronic kidney disease patients display abnormalities in the function of the autonomic nervous system. Such derangements are due to comorbid conditions such as diabetes but also result directly from uremic toxicity. Given the importance of the sympathetic and parasympathetic nervous system in normal sexual function, disturbances in the autonomic nervous system are likely to participate in the genesis of erectile dysfunction. Reductions in nocturnal penile tumescence (NPT) and the frequency of sexual intercourse are positively correlated with disturbances in autonomic function as assessed by the valsalva maneuver.
While adequate penile blood flow and intact neural input are prerequisites for an erectile response, the endocrine system plays an integral role in normal male sexual function ( Table 16.2 ). In men with chronic kidney disease disturbances in the pituitary–gonadal axis can be detected with only moderate reductions in the glomerular filtration rate and progressively worsen as kidney failure progresses. These disorders rarely normalize with initiation of hemodialysis or peritoneal dialysis and, in fact, often progress. By comparison, a well-functioning kidney transplant is much more likely to restore normal sexual activity, although some features of reproductive function may remain impaired.
Men |
↓ Gonadal function |
Decreased production of testosterone |
↓ Hypothalamic–pituitary function |
Blunted increase in serum luteinizing hormone (LH) levels |
Decreased amplitude of LH secretory burst |
Variable increase in serum FSH levels |
Increased prolactin levels |
Women |
Anovulatory menstrual cycles |
Lack of mid-cycle surge in LH |
↑ Prolactin |
Chronic kidney disease is associated with impaired spermatogenesis and testicular damage, often leading to infertility. Semen analysis typically shows a decreased volume of ejaculate, either low or complete azoospermia, and a low percentage of motility. These abnormalities are often apparent before the need for dialysis and then deteriorate further once dialytic therapy is initiated. Histologic changes in the testes show evidence of decreased spermatogenic activity with the greatest changes in the hormonally dependent later stages of spermatogenesis. The number of spermatocytes is reduced and there is little evidence of maturation to the stage of mature sperm. In most instances the number of spermatogonia is normal but on occasion complete aplasia of germinal elements may also be present. Other findings include damage to the seminiferous tubules, interstitial fibrosis, and calcifications. Interstitial fibrosis and calcification also develop in the epididymis and corpora cavernosa particularly as the time on maintenance hemodialysis becomes prolonged.
Unlike other causes of primary testicular disease, the Leydig and Sertoli cells show little evidence of hypertrophy or hyperplasia. This later finding suggests a defect in the hormonal regulation of the Leydig and Sertoli cells as might occur with gonadotropin deficiency or resistance, rather than a cytotoxic effect of uremia where spermatogonia would be most affected. The factors responsible for testicular damage in uremia are not well understood. It is possible that plasticizers in dialysis tubing, such as phthalate, may play a role in propagating the abnormalities once patients are initiated onto maintenance hemodialysis.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here